The Global Cardiopulmonary Bypass Equipment Market Growth Accelerated By Rising Cardiac Diseases Prevalence

Cardiopulmonary Bypass Equipment Market

Cardiopulmonary bypass equipment are used to oxygenate and pump blood during open-heart surgeries such as coronary artery bypass surgery and heart valve surgery. Cardiopulmonary bypass equipment provide partial or complete cardiopulmonary support during surgery, which is vital in maintaining oxygenated blood circulation to vital organs. Increasing prevalence of cardiovascular diseases and rising number of cardiac surgeries are major drivers for growth of the cardiopulmonary bypass equipment market.

The global Cardiopulmonary Bypass Equipment Market is estimated to be valued at US$ 138.26 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Rising prevalence of cardiovascular diseases is a major trend fueling growth of the cardiopulmonary bypass equipment market. According to World Health Organization (WHO), cardiovascular diseases (CVDs) are the number one cause of death globally, taking an estimated 17.9 million lives each year. High blood pressure, tobacco use, unhealthy diet and obesity, physical inactivity and excessive alcohol consumption are key risk factors contributing to the rising CVD burden. Increasing focus on adoption of sedentary lifestyle and consumption of junk food has led to rise in prevalence of associated risk factors over the years, thereby accelerating demand for cardiovascular procedures and cardiopulmonary bypass equipment.

Segment Analysis
The Global Cardiopulmonary Bypass Equipment Market Analysis is dominated by heart-lung machines sub segment. Heart-lung machines held the largest market share in 2020 as these machines are essential during open-heart surgeries and help maintain circulation and oxygenation of blood during operations. Oxygenators sub segment is the fastest growing segment owing to its widespread use in transferring oxygen to and removing carbon dioxide from the blood during cardiopulmonary bypass.

Key Takeaways
The global cardiopulmonary bypass equipment market is expected to witness high growth over the forecast period owing to increasing incidences of cardiovascular diseases and growing numbers of open-heart surgeries globally. The global Cardiopulmonary Bypass Equipment Market is estimated to be valued at US$ 138.26 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2024 to 2031.

Regional analysis
North America dominates the global market and accounted for the largest market share in 2020 due to presence of major players, rising awareness about availability of treatment options and growing volumes of surgical procedures in the region. Europe is expected to be the fastest growing regional market between 2024-2031 backed by growing geriatric population, increasing healthcare expenditure and government support for adopting innovative medical technologies.

Key players
Key players operating in the cardiopulmonary bypass equipment market are Dow, Henkel, BASF, Nordson, LORD Corporation, H.B. Fuller, Siltech Corporation, Qualcomm, Broadcom, Skyworks Solutions, Qorvo. Dow, Henkel and BASF collectively account for over 30% of the global market share owing to their robust product portfolios and widespread distribution networks across major markets.

Get more insights on this topic: https://www.ukwebwire.com/cardiopulmonary-bypass-equipment-market-size-and-share-analysis-growth-trends-and-forecasts/

Explore more information on this topic, Please visit:https://masstamilan.tv/printed-electronics-the-future-of-electronics-manufacturing/